ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership183,075 shares
Latest Disclosed Value $ 14,078,468
Walleye Capital LLC ownership in ANIP / ANI Pharmaceuticals, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 183,075 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $14,078,468 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 117,307 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 56.06% during the quarter. The current value of the position is $14,849,213 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (ANIP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ANIP / ANI Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 183,075 65,768 56.06 14,078 52.03 0.0586
2026-05-08 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 183,075 65,768 14,078 0.0585
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 117,307 -99,000 -45.77 9,260 -53.26 0.0284
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 216,307 182,040 531.24 19,814 786.49 0.0743
2025-08-13 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 34,267 2,983 9.54 2,236 6.73 0.0087
2025-05-14 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 31,284 -40,725 -56.56 2,094 -47.39 0.0095
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 72,009 72,009 3,981 0.0097
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -10,849 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 10,849 10,849 691 0.0012
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -8,489 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 8,489 8,489 493 0.0013
2023-11-14 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,489 8,489 493 0.0013
2020-11-16 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -9,235 -100.00 0 -100.00
2020-08-14 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,235 9,235 299 0.0667
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -239 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 239 -10,663 -97.81 15 -98.11 0.0010
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 10,902 7,246 198.19 794 163.79 0.0473
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 3,656 3,036 489.68 301 584.09 0.0331
2019-08-14 2019-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 620 620 44 0.0072
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 620 44
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM Call 3,400 -41.38 210 -50.35 n/a n/a n/a
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM Call 5,800 -71.98 423 -75.15 n/a n/a n/a
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM Call 20,700 -40.52 1,702 -30.67 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ANI PHARMACEUTICALS COM Call 34,800 2,455 n/a n/a n/a
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM Call 34,800 2,455 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM Put 1,200 -61.29 74 -67.26 n/a n/a n/a
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM Put 3,100 226 n/a n/a n/a
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-03-31 13F/A ANI PHARMACEUTICALS COM Put 2,000 141 n/a n/a n/a
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM Put 2,000 141 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.